シーイーシー、富士通の手のひら静脈認証装置を認証印刷ソリューションに採用

ENGLISH
|
JAPANESE
|
CONNECT WITH US:

2018年02月19日 11時00分

Source: Fujitsu Ltd

シーイーシー、富士通の手のひら静脈認証装置を認証印刷ソリューションに採用

東京, 2018年02月19日 - (JCN Newswire) - 株式会社シーイーシー（以下シーイーシー、注1）は、富士通株式会社（以下富士通、注2）および富士通フロンテック株式会社（注3）が製造・販売する手のひら静脈認証装置「FUJITSU 生体認証 PalmSecure Connect（パームセキュアコネクト）」（以下、PalmSecure Connect）を、認証印刷ソリューション「SmartSESAME SecurePrint！（スマートセサミセキュアプリント）」（以下、SecurePrint！）の認証デバイスに採用しました。シーイーシーは、本ソリューションを2018年4月より販売開始します。

シーイーシーの「SecurePrint！」は、複合機やプリンターの出力時や操作時の本人認証にICカードを活用してきましたが、今回、手のひら静脈認証をラインナップに追加し、セキュリティ強化や利便性向上を図ります。認証デバイスとして採用する富士通の「PalmSecure Connect」は、既存システムや機器に容易に手のひら静脈による認証機能を付与できるため、利用環境を迅速に構築できます。

これにより、複合機やプリンターを利用する際の本人認証強化を図ると同時に、手のひらをかざすだけの認証操作で業務効率化を実現します。

本リリースの詳細は下記URLをご参照ください。
http://pr.fujitsu.com/jp/news/2018/02/19.html

概要：富士通株式会社

詳細は http://jp.fujitsu.com/ をご覧ください。

Source: Fujitsu Ltd
セクター: エレクトロニクス, IT

Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Latest Release

CleverTap

CleverTap Recognized as a 'Strong Performer' in the Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 22, 2024 22:42 JST

Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Nov 22, 2024 11:00 JST

NaaS Technology Inc.

NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth
Nov 21, 2024 22:59 JST

Honda Motor Co, Ltd

Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan
Nov 21, 2024 15:35 JST

Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Nov 21, 2024 09:00 JST

Lexaria Bioscience

ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study
Nov 20, 2024 23:05 JST

Mitsubishi Heavy Industries, Ltd.

Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
Nov 20, 2024 15:30 JST

Eisai

Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
Nov 20, 2024 11:51 JST

Eisai

Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements
Nov 20, 2024 10:24 JST

Kingsoft Corporation Limited

Kingsoft Announces 2024 Third Quarter Results
Nov 19, 2024 18:54 JST

Olympus

NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System
Nov 19, 2024 15:30 JST

Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
Nov 19, 2024 09:02 JST

CleverTap

CleverTap Recognized as a Strong Performer in Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 18, 2024 23:30 JST

NEC Corporation

World's First Successful Trial of Quantum Tokens Created Using Quantum Technology
Nov 18, 2024 17:29 JST

Fujitsu and SAP Fioneer enter partnership to accelerate digital transformation in the insurance industry and deliver services that contribute to customers' sustainable business
Nov 18, 2024 12:31 JST

Toyota Motor Corporation

Expanding Possibilities with the Liquid Hydrogen-Powered GR Corolla in the Season Final Round
Nov 18, 2024 09:25 JST

COP29: Indonesian Special Envoy Hashim Djojohadikusumo Announces EUR 1,2 Billion Green Funding
Nov 16, 2024 18:00 JST

Mitsubishi Heavy Industries, Ltd.

Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of LNG-Powered Roll-on/Roll-off Ship TRANS HARMONY EMERALD in Shimonoseki
Nov 15, 2024 18:58 JST

Eisai

Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment)
Nov 15, 2024 17:33 JST

Eisai

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease
Nov 15, 2024 14:31 JST

More Latest Release >>